<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Apomorphine</title>
	<atom:link href="https://apomorphine.info/?feed=rss2" rel="self" type="application/rss+xml" />
	<link>https://apomorphine.info</link>
	<description>a forgotten treatment for alcoholism</description>
	<lastBuildDate>Sat, 13 Jan 2018 16:45:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.4.8</generator>

<image>
	<url>https://apomorphine.info/wp-content/uploads/2017/11/cropped-Apomorphine_Icon_700x700-32x32.png</url>
	<title>Apomorphine</title>
	<link>https://apomorphine.info</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Facilitating adoption of off-patent, repurposed medicines into NHS clinical practice</title>
		<link>https://apomorphine.info/?p=6874</link>
					<comments>https://apomorphine.info/?p=6874#respond</comments>
		
		<dc:creator><![CDATA[Ap0_Admin]]></dc:creator>
		<pubDate>Sat, 13 Jan 2018 16:45:11 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://apomorphine.info/?p=6874</guid>

					<description><![CDATA[December 2017, The Association of Medical Research Charities published a new report which signals the UK government&#8217;s intention to make it easier to facilitate the adoption of off-patent, repurposed medicines into NHS clinical practice. Medical research is increasingly focusing on how existing medicines, licensed for use in treating particular conditions, can also be investigated for use in [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>December 2017, The Association of Medical Research Charities published a<span style="color: #ff6600;"> <a style="color: #ff6600;" href="https://www.amrc.org.uk/publications">new report</a> </span>which signals the UK government&#8217;s intention to make it easier to facilitate the adoption of off-patent, repurposed medicines into NHS clinical practice.</p>
<p>Medical research is increasingly focusing on how existing medicines, licensed for use in treating particular conditions, can also be investigated for use in treating other conditions.</p>
<p>Apomorphine is one such medicine. Out of patent it&#8217;s used to treat Parkinson&#8217;s Disease and currently being investigated for smoking ceesation.  As the history on this website shows it also has a long and safe track record for use as an addiction treatment for alcohol.</p>
<p>The report provides insights about the repurposing of off-patent medicines, including how the drug regulation system and national bodies can support it and how to navigate the different routes that support access to repurposed drugs for NHS patients.</p>
<div id="themify_builder_content-6874" data-postid="6874" class="themify_builder_content themify_builder_content-6874 themify_builder">
    </div>
<!-- /themify_builder_content -->
]]></content:encoded>
					
					<wfw:commentRss>https://apomorphine.info/?feed=rss2&#038;p=6874</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
